The Ghana Medical Trust Fund (GMTF) has commenced preparations to strengthen specialised healthcare delivery across the country, with global healthcare technology company Philips undertaking assessments of selected health facilities ahead of the installation of critical medical equipment.
The exercise forms part of the Fund’s efforts to retool specialist health facilities, improve diagnostic capacity and expand access to advanced medical services, particularly for patients living with chronic and Non-Communicable Diseases.
A delegation from Philips, the expected supplier of the equipment, met with GMTF management before beginning assessments of beneficiary facilities.
The assessments are aimed at determining the readiness of the selected facilities, identifying installation requirements and establishing the infrastructure needed to ensure the equipment is properly installed and utilised.
Welcoming the delegation, the GMTF Administrator, Adjoa Obuobia Darko-Opoku, outlined the Fund’s four core mandates and its interventions to reduce the financial burden of chronic diseases while strengthening Ghana’s capacity to provide specialised healthcare.
She urged Philips to consider a strategic partnership with the Fund that would extend beyond the conventional supply of medical equipment, particularly through arrangements that could reduce procurement costs and improve access to advanced medical technology.
Ms Darko-Opoku stressed the importance of a sustainable relationship that would support the Fund’s broader vision of transforming specialised healthcare delivery in Ghana.
The Philips delegation welcomed the proposal, indicating the company’s preference for a strategic partnership with the GMTF rather than a conventional buyer-supplier arrangement.
The representatives said such collaboration could create opportunities for the company to support the Fund’s interventions and contribute to strengthening Ghana’s healthcare infrastructure.
The discussions also featured presentations on some of Philips’ technological innovations, including its helium-free three-tier mammography machine, which offers opportunities to improve breast cancer screening and diagnostic services.
The ongoing technical assessments are expected to guide the installation process and ensure that beneficiary health facilities have the necessary infrastructure to accommodate the new equipment.
The planned installations are expected to enhance diagnostic capacity, strengthen specialist care and improve the ability of the facilities to respond to growing demand for advanced medical services.
The engagement represents another step in the GMTF’s efforts to translate its mandate into practical healthcare interventions through collaboration with established global technology providers.
For the Fund, the initiative forms part of its commitment to building a stronger healthcare system in which access to specialised treatment is not determined by a patient’s location or financial circumstances.
